Should You Buy Regeneron Pharmaceuticals Stock Before Oct. 30?
The healthcare company will release its third-quarter results next month.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
2 High-Yield Dividend Stocks Near Their 52-Week Lows That Income Investors Are Sleeping On
Key PointsBoth companies have impressive dividend histories.
UK Treasury minister says her old job as City of London rep is ‘not a conflict’
The City of London is lobbying hard against the prospect of a windfall tax on the banks ahead of the October budget.
- Emma Reynolds, UK Treasury minister, says her former City of London rep job isn't a conflict
- Reynolds gained finance insights during 2019-2024 tenure at TheCityUK
- She supports rules for taxes, opposes windfall tax on banks
Robert Næss: – Det jeg frykter mest
Forvalteren ser en mulig farlig kombo i aksjemarkedet nå.
Inflows into gold ETFs continue to be positive for 10th week in a row
But outflows matched investments last week, with US investors choosing to exit
Gold Fields yields to Northern Star
Henco Kruger delivers the market report, and Theo Vorster, co-founder of Galileo Capital, shares his views on the stock market decline, the weakening of the 10-year government bond, and Gold Fields'…
Realty Income (O) Stock Pays Dividends Monthly. Does That Actually Make It a Better Dividend Stock?
More important than the frequency is the dividend yield -- and that was recently a fat 5.9%.